Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-25 @ 4:49 AM
NCT ID:
NCT02077218
Eligibility Criteria:
Inclusion Criteria:
* Alive and in complete remission at time of enrollment
* Underwent allogeneic HCT after 1995
* Time between HCT and study entry: \>= 2 years
* Have at least one CVRF (hypertension, diabetes, dyslipidemia) at the time of eligibility determination
Exclusion Criteria:
* History of ischemic heart disease, stroke, or cardiomyopathy/congestive heart failure
* Abnormal renal function (glomerular filtration rate \[GFR\] \< 60 mL/min/1.73m2)
* Pregnancy
* Known allergy to intravenous (IV) contrast
* Sustained or symptomatic ventricular dysrhythmias uncontrolled with drug therapy or implantable device; significant conduction defects (i.e.: second or third degree atrioventricular block or sick sinus syndrome)
* Current clinical evidence of moderate-to-severe obstructive pulmonary disease or reactive airway diseases (i.e.: asthma) requiring therapy
* History of drug sensitivity or allergic reaction to beta-blockers
* Currently taking calcium channel blockers such as verapramil and diltiazem
* History of unrepaired severe aortic stenosis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT02077218
Study Brief:
Protocol Section:
NCT02077218